|
Volumn 170, Issue 6, 1999, Pages 283-284
|
Colorectal cancer (multiple letters) [1]
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
FOLINIC ACID;
AUSTRALIA;
CANADA;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER PREVENTION;
CANCER RISK;
CANCER SCREENING;
CANCER SURGERY;
COLONOSCOPY;
COLORECTAL CANCER;
EVIDENCE BASED MEDICINE;
HUMAN;
LETTER;
PRACTICE GUIDELINE;
UNITED KINGDOM;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
COLORECTAL TUMOR;
NOTE;
CLINICAL TRIAL;
COLON TUMOR;
MORTALITY;
GENETIC PREDISPOSITION;
GENETICS;
MASS SCREENING;
RISK FACTOR;
ANTINEOPLASTIC AGENTS;
AUSTRALIA;
CHEMOTHERAPY, ADJUVANT;
COLORECTAL NEOPLASMS;
HUMANS;
PRACTICE GUIDELINES;
RADIOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
COLONIC NEOPLASMS;
COLONOSCOPY;
GENETIC PREDISPOSITION TO DISEASE;
MASS SCREENING;
RISK FACTORS;
|
EID: 0033559318
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.1999.tb127761.x Document Type: Letter |
Times cited : (2)
|
References (0)
|